Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 2873 entries
View as:

A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06113289 Org: User:
Start: 02/08/24 End: 03/06/25 Due: 03/06/26

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00966277 Org: User:
Start: 04/30/10 End: 09/30/14 Due: 09/30/15

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

Phase: N/A Priority: Normal
NCT ID: NCT00535873 Org: User:
Start: 10/31/07 End: 02/28/13 Due: 02/28/14

A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

Phase: N/A Priority: Normal
NCT ID: NCT06021600 Org: User:
Start: 10/09/23 End: 12/31/27 Due: 12/31/28

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Phase: N/A Priority: Normal
NCT ID: NCT01772771 Org: User:
Start: 03/01/12 End: 03/01/33 Due: 03/01/34

Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)

Phase: N/A Priority: Normal
NCT ID: NCT01201694 Org: User:
Start: 10/31/11 End: 01/31/14 Due: 01/31/15

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03610490 Org: User:
Start: 10/16/18 End: 08/21/24 Due: 08/21/25

FDG-PET-CT and Biomarkers in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00833625 Org: User:
Start: 02/28/09 End: 12/31/15 Due: 12/31/16

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04771806 Org: User:
Start: 04/01/19 End: 02/02/27 Due: 02/02/28

Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04220775 Org: User:
Start: 03/18/20 End: 10/03/22 Due: 10/03/23

Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03012399 Org: User:
Start: 03/07/17 End: 04/30/27 Due: 04/30/28

Cord Blood Expansion on Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT00498316 Org: User:
Start: 07/03/07 End: 10/31/16 Due: 10/31/17

Patient Reported Symptom Control With THC or CBD Use

Phase: N/A Priority: Normal
NCT ID: NCT04875286 Org: User:
Start: 02/03/21 End: 02/02/27 Due: 02/02/28

The Rise in Robotic Atypical Segmentectomies

Phase: N/A Priority: Normal
NCT ID: NCT04644952 Org: User:
Start: 09/15/20 End: 04/30/27 Due: 04/30/28

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02971748 Org: User:
Start: 01/26/17 End: 12/31/25 Due: 12/31/26

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02949947 Org: User:
Start: 12/18/17 End: 03/06/19 Due: 03/06/20

E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05549687 Org: User:
Start: 05/19/17 End: 08/07/23 Due: 08/07/24

Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies

Phase: N/A Priority: Normal
NCT ID: NCT04003051 Org: User:
Start: 03/18/19 End: 12/31/26 Due: 12/31/27

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06207799 Org: User:
Start: 07/17/24 End: 12/31/31 Due: 12/31/32

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT02385110 Org: User:
Start: 09/23/15 End: 01/24/23 Due: 01/24/24

Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02950038 Org: User:
Start: 12/31/16 End: - Due: -

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04169763 Org: User:
Start: 08/07/20 End: 12/31/26 Due: 12/31/27

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03772834 Org: User:
Start: 03/25/19 End: 11/30/26 Due: 11/30/27

Lenalidomide and Paclitaxel in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00933426 Org: User:
Start: 08/31/09 End: 12/31/15 Due: 12/31/16

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Phase: N/A Priority: Normal
NCT ID: NCT03485950 Org: User:
Start: 05/16/18 End: 02/16/22 Due: 02/16/23